SERAFIN, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.846
AS - Asia 2.385
EU - Europa 1.126
AF - Africa 399
SA - Sud America 346
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 44
Totale 8.225
Nazione #
US - Stati Uniti d'America 3.589
SG - Singapore 739
CN - Cina 463
VN - Vietnam 363
IT - Italia 271
HK - Hong Kong 243
BR - Brasile 207
DE - Germania 126
PL - Polonia 84
IN - India 81
FR - Francia 78
FI - Finlandia 76
BD - Bangladesh 69
CA - Canada 59
GB - Regno Unito 59
NL - Olanda 51
RU - Federazione Russa 45
SE - Svezia 36
ZA - Sudafrica 33
AT - Austria 32
BJ - Benin 30
TR - Turchia 30
AR - Argentina 29
MX - Messico 29
IQ - Iraq 26
JP - Giappone 25
SA - Arabia Saudita 25
KR - Corea 24
CI - Costa d'Avorio 22
UZ - Uzbekistan 22
EC - Ecuador 21
UA - Ucraina 21
HN - Honduras 20
JM - Giamaica 20
PK - Pakistan 20
TN - Tunisia 20
ES - Italia 19
ID - Indonesia 19
PH - Filippine 19
KE - Kenya 17
VE - Venezuela 16
BO - Bolivia 15
IE - Irlanda 15
KG - Kirghizistan 15
BW - Botswana 14
JO - Giordania 14
PE - Perù 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
DK - Danimarca 13
NO - Norvegia 13
AU - Australia 12
CH - Svizzera 12
EE - Estonia 12
EG - Egitto 12
GH - Ghana 12
IL - Israele 12
MA - Marocco 12
ML - Mali 12
NI - Nicaragua 12
NZ - Nuova Zelanda 12
SI - Slovenia 12
TJ - Tagikistan 12
UY - Uruguay 12
AM - Armenia 11
AO - Angola 11
BZ - Belize 11
CM - Camerun 11
HU - Ungheria 11
LV - Lettonia 11
YE - Yemen 11
AL - Albania 10
GE - Georgia 10
HT - Haiti 10
MK - Macedonia 10
MY - Malesia 10
NA - Namibia 10
PS - Palestinian Territory 10
RO - Romania 10
UG - Uganda 10
XK - ???statistics.table.value.countryCode.XK??? 10
AZ - Azerbaigian 9
BB - Barbados 9
BF - Burkina Faso 9
CD - Congo 9
CL - Cile 9
CR - Costa Rica 9
DZ - Algeria 9
ET - Etiopia 9
GA - Gabon 9
GR - Grecia 9
IS - Islanda 9
PA - Panama 9
TH - Thailandia 9
BA - Bosnia-Erzegovina 8
BS - Bahamas 8
CV - Capo Verde 8
CW - ???statistics.table.value.countryCode.CW??? 8
IR - Iran 8
KZ - Kazakistan 8
Totale 7.815
Città #
Ashburn 552
Singapore 445
San Jose 417
Fairfield 313
Hong Kong 224
Chandler 196
Woodbridge 138
Cambridge 134
Houston 126
Seattle 116
Ho Chi Minh City 112
Beijing 106
Hanoi 101
Wilmington 94
Ann Arbor 91
Santa Clara 89
Los Angeles 78
Boardman 48
Helsinki 48
New York 44
San Diego 44
Padova 43
Council Bluffs 38
Munich 36
Cotonou 30
Bytom 29
Lauterbourg 29
Princeton 29
Chicago 27
Des Moines 27
Medford 27
Gdansk 26
Milan 24
Buffalo 23
Montreal 23
Abidjan 22
Denver 21
Orem 21
Tashkent 21
Haiphong 20
Johannesburg 20
São Paulo 20
Vienna 20
Warsaw 20
Tokyo 19
Guangzhou 18
Hefei 18
Atlanta 17
Da Nang 17
London 17
Chennai 16
Redondo Beach 15
Bishkek 14
Nuremberg 14
Amman 13
Frankfurt am Main 13
Guayaquil 13
Nairobi 13
Nanjing 13
San Pedro Sula 13
Seoul 13
Turku 13
Brooklyn 12
Dallas 12
Kingston 12
Padua 12
Rome 12
Bamako 11
Dublin 11
Dushanbe 11
Gaborone 11
Managua 11
Rio de Janeiro 11
Accra 10
Kampala 10
La Paz 10
Luanda 10
Montevideo 10
Shenyang 10
Baku 9
Hải Dương 9
Istanbul 9
Jeddah 9
Libreville 9
Riga 9
Stockholm 9
Tunis 9
Yerevan 9
Addis Ababa 8
Amsterdam 8
Belize City 8
Bridgetown 8
Erbil 8
Kingstown 8
Kinshasa 8
Kuala Lumpur 8
Lappeenranta 8
Mexico City 8
Nassau 8
Panama City 8
Totale 4.744
Nome #
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 426
A rhabdomyosarcoma hydrogel model to unveil cell-extracellular matrix interactions 306
Large-scale circular RNA deregulation in T-ALL: Unlocking unique ectopic expression of molecular subtypes 303
NOTCH3 SIGNALING REGULATES MUSASHI-1 EXPRESSION IN METASTATIC COLORECTAL CANCER CELLS. 288
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. 284
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 281
CircFBXW7 in patients with T-cell ALL: depletion sustains MYC and NOTCH activation and leukemia cell viability 275
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 274
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 273
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 267
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 267
MODULATION OF MICRORNA EXPRESSION IN HUMAN T CELL DEVELOPMENT: TARGETING OF NOTCH3 BY MIR-150 267
Proteomic Alterations in Response to Hypoxia Inducible Factor 2α in Normoxic Neuroblastoma Cells 259
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 253
Notch3 signalling promotes tumour growth in colorectal cancer 252
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 248
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 245
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 235
A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features 234
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 233
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients 211
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia 208
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion 207
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia 200
Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts 188
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia 183
NUP214-ABL1 fusion in childhood T-ALL 173
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 169
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation 169
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit 158
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 158
Notch3 signalling promotes tumour growth in colorectal cancer: implication for Notch target therapy 145
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 142
Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia 129
Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia 123
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 122
NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT/β-catenin pathway 70
Totale 8.225
Categoria #
all - tutte 24.217
article - articoli 23.001
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.218


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022451 0 25 26 23 38 25 118 20 28 13 58 77
2022/2023405 62 48 17 51 38 50 5 25 51 4 18 36
2023/2024311 12 46 44 26 24 37 30 17 16 14 22 23
2024/20251.034 2 63 49 37 104 29 56 91 97 49 172 285
2025/20264.612 265 312 555 758 420 190 695 333 568 235 187 94
2026/2027368 172 196 0 0 0 0 0 0 0 0 0 0
Totale 8.225